Grigg, A
Butcher, B
Khodr, B
Bajel, A
Hertzberg, M
Patil, S
D'Souza, A B
Ganly, P
Ebeling, P
Wong, E
,
Article History
Received: 2 March 2017
Revised: 25 April 2017
Accepted: 28 April 2017
First Online: 19 June 2017
Competing interests
: BB received payment for statistical services from the Australasian Leukaemia and Lymphoma Group (ALLG), and received consulting fees from Novartis for other unrelated work. AB has received honoraria from Novartis. The remaining authors declare no conflict of interest.